Industry Segment: Market Brief | Word Count: 103 Words

South America's Pharmaceutical & Biotech Industry has begun to feel the impact of COVID-19, and most companies are postponing maintenance and capital projects, and only focusing on operating plants with essential staff.

For instance, Brazilian company Geolab stopped construction on a project in Anapolis, Goias, where the project's completion may take at least four more months. The same situation is happening with a grassroot project in Chorrillos, Peru, where Laboratorios Induquimica has re-scheduled authorization for expenditure within six months. In Argentina, Sinergium Biotech may not review the authorization for expenditure for its line addition project in Garin, Buenos Aires, until July.